Lung diseases claim millions of lives globally each year, with limited treatment options and inadequate animal models for research. Now, researchers have made a significant advancement by developing a mucus-based bioink for 3D printing lung tissue, as detailed in a study published in ACS Applied Bio Materials. This innovation holds promise for better understanding and treating chronic lung conditions.
While lung transplants offer a lifeline to some, the shortage of donor organs limits this option. Medications and treatments can manage symptoms of diseases like chronic obstructive pulmonary disease (COPD) and cystic fibrosis, but no cure exists. Traditional research methods using rodents often fall short in accurately replicating human pulmonary diseases and predicting drug safety and efficacy. In response, bioengineers are turning to lab-grown lung tissue, aiming to create more precise models or potential implant materials.
Continue reading… “Breakthrough in Lung Disease Research: 3D-Printed Lung Tissue Using Mucus-Based Bioink”
